OPAPDFY23003: American Palestinian Arts, Culture, and Sports Initiative
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of U.S. Mission to Jerusalem notices from 2023.
U.S. Mission to Jerusalem offered grants of up to $100,000 (at least $50,000) to nonprofits. It expected to make about 2 awards worth $100,000 in total. Applications closed on June 4, 2023.
From the official notice on Grants.gov, last changed May 3, 2023. Checked November 7, 2026.
- Award ceiling$100,000
- Award floor$50,000
- Total funding$100,000
- Expected awards2
- Cost sharingNot required
- Funding typeCooperative Agreement, Grant, Other
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| OPAPDFY22010 | July 25, 2022 | Closed August 22, 2022 | Closed |
Key dates
| Posted | May 3, 2023 |
|---|---|
| Deadline | June 4, 2023 |
| Archived by Grants.gov | July 4, 2023 |
Who can apply
This opportunity was open to nonprofits.
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Is this a realistic fit?
- Past Investing in People in The Middle East and North Africa awards averaged $94,415; this notice allows up to $100,000 per award.
- Most of the program's money (52% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
A. PROGRAM DESCRIPTION The Public Diplomacy Section (PD) of the U.S. Office of Palestinian Affairs (U.S. OPA) announces an open competition for a grant through this Notice of Funding Opportunity (NOFO). The American Palestinian Arts, Culture, and Sports Initiative is designed to partner with American and/or Palestinian non-profit organizations to implement activities which advance the applicant’s goals and the U.S.OPA mission, including but not limited to building Palestinian institutions, both governmental and non-governmental, that effectively address the needs and aspirations of the Palestinian people and building a prosperous Palestinian economy, led by a thriving private sector, that provides equitable and inclusive economic opportunities and improves daily life for Palestinians. The proposal must include substantive engagement with American people, institutions, ideas and ideals in order to improve American-Palestinian relations and create greater opportunities for mutually beneficial partnership and cooperation. Priority Region: Jerusalem, West Bank, and Gaza or a combination of two or three of them. Program Objectives: All proposed projects must aim to advance the U.S. OPA mission goals stated above, contain a substantive American element, and achieve one or more of the following specific objectives: · Increase understanding and collaboration between Americans and Palestinians via direct exchange with American arts, film, music, dance, theatre, cultural, and/or sports professionals or institutions. Activities may include joint performances, productions, exhibits, workshops, tournaments, trainings, and other projects/works among other ideas. · Enhance employability, entrepreneurship, and/or careers of artists, creatives, arts, cultural and sports professionals · Positively address issues of conflict resolution, mental health, resiliency, or trauma therapy through arts, culture, and/or sports · Promote diversity, equity, inclusion, and accessibility, environmental protection, human rights, and/or a strong civil society via arts, culture, and/or sports activities and exchange. Special consideration will be given to proposals that demonstrate how the program advances diversity, equity, inclusion, and/or accessibility with respect to race, ethnicity, religion, income, geography, gender identity, sexual orientation, and/or disability.
Who has won Investing in People in The Middle East and North Africa grants before
From fiscal 2021 to 2025, Investing in People in The Middle East and North Africa (19.021) awarded $55.5 million across 588 grant awards, an average of $94,415 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| America-Mideast Educational and Training Services, Inc. | District of Columbia | 67 | $7.9 million |
| World Learning Inc. | Vermont | 9 | $7.0 million |
| International Research and Exchanges Board Inc. | District of Columbia | 9 | $5.8 million |
| University of Notre Dame Du Lac | Indiana | 1 | $3.9 million |
| Miscellaneous Foreign Awardees | 72 | $3.1 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is OPAPDFY23003 still open?
No. It closed on June 4, 2023.
Who can apply for American Palestinian Arts, Culture, and Sports Initiative?
U.S. Mission to Jerusalem accepted applications from nonprofits.
What is the deadline for American Palestinian Arts, Culture, and Sports Initiative?
Closed June 4, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $100,000 each. About $100,000 in total across about 2 awards.
Who has won Investing in People in The Middle East and North Africa grants before?
The largest recipients over five fiscal years were America-Mideast Educational and Training Services, Inc., World Learning Inc., International Research and Exchanges Board Inc. The program made 588 awards worth $55.5 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)